Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program.
Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program. According to Julie Ross, Executive Vice President of Advanced Clinical, “A cloud-based eTMF gives us and our clients a strategic advantage. We can speed document collection from start-up through trial close, and our clients get the visibility they need throughout the entire study.” Through the Veeva CRO Partnership Program, Advanced Clinical received expert training and implementation support, and is prepared to deploy Vault eTMF for new and existing studies. Going forward, Advanced Clinical will receive regular checks and training on system updates. Also, as a CRO partner, they benefit from ongoing strategy sessions and Veeva’s marketing outreach.
Veeva Systems announced the new CRO partnership program to support growing trends in eTMF outsourcing and cloud adoption. In a recent Applied Clinical Trials article, http://bit.ly/I1prg6, the author observed that technology vendors are working closely with CROs in developing partner programs that benefit both the CRO as well as the sponsor. "Vendors have implemented strictly controlled, high quality training and testing programs along with user testing (certification), company accreditation and associated branding to recognize high quality CRO partners who are familiar with their technology.”
The full release can be read here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.